Please login to the form below

Not currently logged in
Email:
Password:

Sciterion appoints Gabi Cutayar as new MD

Previously served as business director at McCann Health

Gabi Cutayar

Scientific communications agency Sciterion has appointed Gabi Cutayar (pictured above) as its new managing director. 

Most recently, Cutayar worked as business director at McCann Health, where she led a multidisciplinary team.

Previously, she worked as a director at Havas Life Medicom, where she led the business for a multi-million-pound global client.

Cutayar is also a trained pharmacist, and brings extensive pharma and bioscience industry experience to the team at Sciterion.

“I’m delighted to be part of such an energetic and passionate team who consistently bring science to life in evidence-based and creative ways,” said Cutayar.

“I look forward to leading Sciterion into our next chapter as we continue to innovate beyond the traditional and take scientific communications to the next level,” she added.

In her new role, she will be responsible for the day-to-day leadership of the agency, business development and strengthening Sciterion’s scientific communications and medical education offerings.

“Gabi has the right skill set and experience to push Sciterion forward in the scientific communications arena,” said Gaynor Hayburn, group managing director.

“Her collaborative nature means we can maximise the opportunities to work with our Havas partners around the globe to continue to grow the business and deliver exceptional work for our clients,” she added.

5th December 2019

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics